May 30, 2018 4:35pm EDT IMV Leadership to Participate in Upcoming Investor and Business Development Conferences
May 25, 2018 4:05pm EDT IMV (Formerly Immunovaccine Inc.) to Present at the National Bank Financial Quebec Conference in Toronto
May 03, 2018 7:05am EDT Immunovaccine Inc. Has Applied to List its Common Shares on Nasdaq, Announces Reverse Stock Split
Apr 26, 2018 7:05am EDT Immunovaccine to Highlight Clinical Data for Its Lead Candidate in Oral Presentation at 54th Annual Meeting of the American Society of Clinical Oncology
Apr 24, 2018 7:05am EDT Immunovaccine and Incyte Expand Clinical Collaboration Evaluating Combination Immunotherapies in Advanced Recurrent Ovarian Cancer
Apr 23, 2018 7:05am EDT Immunovaccine to Present at Bloom Burton & Co. Healthcare Investor Conference
